Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent - 05/09/11
Doi : 10.1016/S0190-9622(00)90233-0
Takeshi Kono, MDa, Masamitsu Ishii, MDa, Nobuo Negoro, MDb, Shoji Taniguchi, MDc
Osaka, Japan
From the Department of Dermatologya and the First Department of Internal Medicine,b Osaka City University Medical School, and the Department of Dermatology,c Osaka General Hospital of the West Japan Railway Company
Abstract |
UFT, a combination of uracil and tegafur, is a second-generation anticancer agent. UFT has been used in Japan, other Asian countries, South America, and Russia. Recently, UFT has been extensively studied for colorectal, pancreatic, and various types of cancer in North America and Europe, especially with leukovorin. We report a case of a scleroderma-like reaction induced by long-term administration of UFT. This is the first report of UFT-induced scleroderma-like reaction. (J Am Acad Dermatol 2000;42:519-20.)
Le texte complet de cet article est disponible en PDF.Plan
 | Reprint requests: Takeshi Kono, MD, Department of Dermatology, Osaka City University Medical School, 1-4-7, Asahimachi, Abeno-ku, Osaka 545-8585, Japan. |
© 2000
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 42 - N° 3
P. 519-520 - mars 2000 Retour au numéro
Article précédent
- Linear verrucous hemangioma
- Utta Wentscher, Rudolf Happle
- A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus
- Yasushi Suga, Ryoji Tsuboi, Yukiko Hashimoto, Takashi Yoshiike, Hideoki Ogawa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?